Burzynski Research Institute, Inc.
|
-0.01 USD
|
-1370.588%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
93.392%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
101.449%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-1019.403%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-367.29%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
102.521%
|
Qrons Inc.
|
-0.06 USD
|
-157.29%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-9900.0%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-160.87%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-1400.0%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
97.207%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
99.705%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-191.262%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
94.565%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-71.625%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-532.911%
|
Mesoblast Limited
|
-0.09 USD
|
-68.35%
|
Marizyme, Inc.
|
-1.44 USD
|
89.583%
|
Genus plc
|
0.12 USD
|
225.0%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
93.562%
|
Pharming Group N.V.
|
-0.02 USD
|
-831.677%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-21328.571%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
64.286%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-55.44%
|
ContraFect Corporation
|
-124.97 USD
|
99.88%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-257.143%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-1150.0%
|
IMV Inc.
|
-4.37 USD
|
96.568%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-323.729%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-149900.0%
|
ONE Bio Corp.
|
1.43 USD
|
110.49%
|
Accustem Sciences Inc.
|
-0.34 USD
|
55.882%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
74.138%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-25.0%
|
Q BioMed Inc.
|
-0.08 USD
|
-92.061%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-113.371%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
54.545%
|
Biomind Labs Inc.
|
-0.02 USD
|
-825.926%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.981%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-1927.027%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-653.769%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-6150.0%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-18650.0%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
42.308%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-1604.545%
|
GB Sciences, Inc.
|
-0.00 USD
|
-3558.537%
|
HST Global, Inc.
|
-0.03 USD
|
-437.634%
|
CSL Limited
|
2.73 USD
|
105.495%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-199.401%
|
Halberd Corporation
|
-0.00 USD
|
-149900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-21328.571%
|
Agentix Corp.
|
-0.04 USD
|
-328.571%
|
Resverlogix Corp.
|
-0.01 USD
|
-956.338%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-98.939%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
97.093%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
11638.462%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
697.61%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-320.168%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-650.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-178.293%
|
Zenith Capital Corp.
|
-0.07 USD
|
-114.592%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-230.396%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-2280.952%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
96.021%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-29900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-64.294%
|
Kadimastem Ltd
|
-0.78 USD
|
80.769%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
96.809%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
99.588%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
75.806%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-1160.504%
|
LadRx Corporation
|
0.68 USD
|
122.059%
|
Cell Source, Inc.
|
-0.17 USD
|
11.765%
|
Regen BioPharma, Inc.
|
0.29 USD
|
151.724%
|
Regen BioPharma, Inc.
|
0.26 USD
|
157.692%
|
NovAccess Global Inc.
|
-0.23 USD
|
34.783%
|
Affymax, Inc.
|
-0.39 USD
|
61.538%
|
Itoco Inc.
|
-0.01 USD
|
-1873.684%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-1400.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-5900.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-2578.571%
|
CytoDyn Inc.
|
-0.05 USD
|
-183.554%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-29900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-575.676%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.902%
|
SYBLEU INC
|
-0.02 USD
|
-757.143%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-956.338%
|
International Stem Cell Corporation
|
-0.02 USD
|
-814.634%
|
Bioxytran, Inc.
|
-0.03 USD
|
-370.219%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-149900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
98.123%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
87.288%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-341.176%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-2280.952%
|
Neutra Corp.
|
-0.00 USD
|
-149900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.841%
|
PureTech Health plc
|
-2.38 USD
|
93.697%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
81.928%
|
IXICO plc
|
-0.02 USD
|
-514.754%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-164.085%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
88.889%
|
CSL Limited
|
5.47 USD
|
102.742%
|
Cellectis S.A.
|
-1.77 USD
|
91.525%
|